search
metabolism drugs
Trends
- 1Zepbound and Mounjaro may activate calorie-burning brown fat▼Zepbound and Mounjaro may turn on the body’s calorie-burning brown fat
New research suggests the weight-loss drugs Zepbound and Mounjaro may activate brown fat, a type of body tissue that burns calories to generate heat. If confirmed, the findings could help explain part of how the medications drive weight loss beyond appetite suppression, and point to new ways of boosting metabolism in obesity treatment.
- 2
Researchers report that metabolism drugs already approved for other uses reversed signs of spinal muscular atrophy (SMA) in mouse models. Because these treatments have cleared regulatory safety hurdles, the findings could speed up testing in SMA patients. The work is drawing attention in the biology and rare disease communities as a potential new, faster route to therapy beyond existing genetic treatments.
- 3Inventiva Reports Unaudited First-Half 2026 Results and Corporate Update▼Inventiva Reports Unaudited 2026 First-Half Financial Results and Provides Corporate Update
French biopharmaceutical company Inventiva has published unaudited financial results for the first half of 2026, alongside a corporate update on its business. The company, known for developing treatments for metabolic diseases such as NASH, released the figures through standard financial news channels. Details on revenue, cash position and pipeline progress were included in the announcement.